Position in FTRE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$17,170,483
New position
Shares Held
1,822,769
first reported quarter
Ownership
1.93%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 98.17892448247693.ToString("F0")%
Shared 0.ToString("F0")%
None 1.821075517523065.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026LOOMIS SAYLES & CO L P holds $4,075,180,510 across 25 Biotechnology names. FTRE ranks #21 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,003,821 | $1,787,866,229 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,912,310 | $1,477,527,197 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
512,097 | $169,437,533 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
353,209 | $70,518,176 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
968,135 | $46,054,181 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
475,324 | $43,910,430 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
256,625 | $43,374,756 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
465,102 | $40,449,920 |
All Filings in FTRE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,170,483 | 1,822,769 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||